NCT05694481

Brief Summary

An observational clinical study on the changes of intestinal flora between people with circadian rhythm disorders and healthy controls was conducted to explore the relationship between circadian rhythm disorders and human intestinal microorganisms. To reveal the effects of circadian rhythm disorder on human intestinal microorganisms and metabolism on other potential diseases. In this study, 40 people with circadian disorders and 40 healthy controls were recruited. During the study, blood, urine and fecal samples of the subjects were obtained once, and the obtained biological samples were tested and analyzed by serum, urine metabolomics and fecal metagenomics. Subjects were also evaluated on the following scales : Circadian Type Inventory(CTI ). The Epworth Sleeping Scale ( ESS ), Fatigue Scale-14 ( FS-14 ), Maslach Burnout Inventory-General Survey ( MBI-GS ), Athens Insomnia Scale ( AIS ), Insomnia Severity Index ( ISI ), Pittsburgh sleep quality index ( PSQI ), Bristol Stool Scale, Gastrointestinal Symptom Rating Scale ( GSRS ), Connor-Davidson resi.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2022

Completed
19 days until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

January 23, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

January 23, 2023

Status Verified

January 1, 2023

Enrollment Period

2 months

First QC Date

December 13, 2022

Last Update Submit

January 12, 2023

Conditions

Keywords

Circadian rhythmGut microbiotaMetabolomicsMetagenomes

Outcome Measures

Primary Outcomes (1)

  • Change of gut microbiota

    Alpha and Beta diversity of gut microbiota by metagenome. function and sequence-based analysis of gut microbiota microbial genome. The differential flora was obtained through differential analysis, and the correlation analysis was carried out between the differential flora and the differential metabolites. The difference in gut microbiota between people with circadian rhythm disorder and health controls is understood through stool detection.

    Only once. The experimental group shall fill in immediately after the end of the night shift and the control group shall fill in during work. (8:00 until 12:00)

Secondary Outcomes (10)

  • Changes in metabolites of gut microbiota

    Only once.The experimental group shall fill in immediately after the end of the night shift and the control group shall fill in during work. (8:00 until 12:00)

  • Changes of serum metabolites

    Only once.The experimental group shall fill in immediately after the end of the night shift and the control group shall fill in during work. (8:00 until 12:00)

  • Changes of urine metabolites

    Only once.The experimental group shall fill in immediately after the end of the night shift and the control group shall fill in during work. (8:00 until 12:00)

  • Circadian Type Inventory

    Only once.The experimental group shall fill in immediately after the end of the night shift and the control group shall fill in during work. (8:00 until 12:00)

  • Gastrointestinal Symptom Rating Scale (GSRS)

    Only once.The experimental group shall fill in immediately after the end of the night shift and the control group shall fill in during work. (8:00 until 12:00)

  • +5 more secondary outcomes

Study Arms (2)

Circadian rhythm disorders

Observational, no intervention administered.

Healthy controls

Observational, no intervention administered.

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The subjects of the study will recruit employees with certain regularity who are engaged in night or day shifts from Daping Hospital of Army Medical University.

You may qualify if:

  • All genders, Age18\~75,
  • Regular night shift or day shift,
  • No antibiotics and probiotics within one month,
  • Possess understanding and communicate ability;no severe disease,no mental disorders,
  • Fully informed consent, willing to participate in this study.

You may not qualify if:

  • Not willing to participate in this study,
  • Patients with severe cognitive impairment or mental illness,
  • Alcohol and drug dependence,
  • The sleep disorder by alcohol and Coffee and/or Strong tea,
  • No other Tranquilizers treatment was received within 1 week before the drug was used in this clinical trial,
  • Severe intestinal infection, such as salmonella, shigella, pestis, etc,
  • Pregnant or lactating women,
  • Other reasons not suitable for clinical trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gastroenterology, Daping Hospital, The Third Military Medical University

Chongqing, Chongqing Municipality, 400042, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

serum, feces, urine Serum refers to the light yellow transparent liquid separated from plasma by removing fibrinogen after blood coagulation. Faecalis, refers to the excretion of human and animal. Urine, is a fluid like metabolite excreted from the human body.

MeSH Terms

Conditions

Chronobiology Disorders

Condition Hierarchy (Ancestors)

Nervous System Diseases

Study Officials

  • Yanling Wei*, MD

    Daping Hospital, Army medical university

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate chief physician / Associate professor

Study Record Dates

First Submitted

December 13, 2022

First Posted

January 23, 2023

Study Start

January 1, 2023

Primary Completion

March 1, 2023

Study Completion

March 1, 2023

Last Updated

January 23, 2023

Record last verified: 2023-01

Locations